Literature DB >> 2183586

Expression of aldolase C isozyme in renal cell carcinoma.

M Takashi1, H Haimoto, T Koshikawa, K Kato.   

Abstract

The authors localized aldolase C in renal tubules and renal cell carcinoma by immunohistochemical study and quantitative analysis by an enzyme immunoassay. Aldolase C was localized in epithelial cells of loops of Henle and collecting ducts and in those of Bowman's capsules. In renal cell carcinoma, aldolase C was immunohistochemically demonstrated in 95% (41 of 43) of cases, including one sarcomatoid variant. The tissue concentrations of aldolase C in the renal cortex (n = 8) were 12.7 +/- 6.2 micrograms/g protein (mean +/- standard deviation), and those of the medulla (n = 8) were 20.3 +/- 6.9 micrograms/g protein. On the other hand, the concentrations in renal cell carcinoma (n = 26) were 93.5 +/- 95.9 micrograms/g protein: about seven times higher than that in renal cortex (P less than 0.001). These findings indicate that aldolase C was first expressed in renal cell carcinoma, which is derived from proximal renal tubules, because proximal renal tubules had aldolase B but not aldolase C.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2183586     DOI: 10.1093/ajcp/93.5.631

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  5 in total

1.  Aldolase mRNA expression in endometrial cancer and the role of clotrimazole in endometrial cancer cell viability and morphology.

Authors:  Paulette Mhawech-Fauceglia; Dan Wang; Joshua Kesterson; Amy Beck; Karen L de Mesy Bentley; Stuti Shroff; Susanna Syriac; Peter Frederick; Song Liu; Kunle Odunsi
Journal:  Histopathology       Date:  2011-09-21       Impact factor: 5.087

2.  Aldolase C/zebrin gene regulation by prolactin during pregnancy and lactation.

Authors:  Manabu Matsuda; Jason A Lockefeer; Nelson D Horseman
Journal:  Endocrine       Date:  2003 Feb-Mar       Impact factor: 3.633

3.  Mass spectrometry in cancer biomarker research: a case for immunodepletion of abundant blood-derived proteins from clinical tissue specimens.

Authors:  Darue A Prieto; Donald J Johann; Bih-Rong Wei; Xiaoying Ye; King C Chan; Dwight V Nissley; R Mark Simpson; Deborah E Citrin; Crystal L Mackall; W Marston Linehan; Josip Blonder
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

4.  Elevated levels of serum aldolase A in patients with renal cell carcinoma.

Authors:  M Takashi; Y Zhu; Y Nakano; K Miyake; K Kato
Journal:  Urol Res       Date:  1992

5.  The role of hypoxic-inducible factor (HIF1α) and aldolaseC protein in endometrial carcinogenesis: a retrospective study of 279 patients.

Authors:  Paulette Mhawech-Fauceglia; Dan Wang; Damanzoopinder Samrao; Teodulo Menesses; Heidi Godoy; Faith Ough; Shashikant Lele; Song Liu; Tanja Pejovic
Journal:  BMJ Open       Date:  2012-08-24       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.